Inhibition of DCLK1 Sensitizes Resistant Lung Adenocarcinomas to EGFR-TKI through Suppression of Wnt/β-Catenin Activity and Cancer Stemness

The authors investigated the role of the tumor stem cell marker DCLK1 in epithelial growth factor receptor-tyrosine kinase inhibitor resistance of lung adenocarcinoma.